Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
AboutMethodSourcesNewsletter
Insider tradingForm 4

BioCardia, Inc. (BCDA) Insider Trading

7 open-market trades reported since Aug 13, 2026: 7 purchases worth $11K and 0 sales worth $0.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Peter AltmanCEO7$11K0$0Oct 20, 2026

All trades

BCDA insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 20Oct 16Peter AltmanCEOCEO▲ BUY3000.95$285+0.1%Form 4 ↗
Oct 20Oct 15Peter AltmanCEOCEO▲ BUY2000.95$190+0.1%Form 4 ↗
Sep 30Sep 29Peter AltmanCEOCEO▲ BUY1,0001.03$1K+0.3%Form 4 ↗
Sep 23Sep 23Peter AltmanCEOCEO▲ BUY1,9001.05$2K+0.5%Form 4 ↗
Sep 4Sep 3Peter AltmanCEOCEO▲ BUY8001.09$872+0.2%Form 4 ↗
Aug 18Aug 17Peter AltmanCEOCEO▲ BUY5,4000.93$5K+1.4%Form 4 ↗
Aug 13Aug 13Peter AltmanCEOCEO▲ BUY1,9000.92$2K+0.5%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings